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Recent studies indicate that the selected micro-and macro-
elements and vitamins may significantly influence the risk
of cancer. Folic acid is necessary for DNA synthesis and
repair, plays an important role in one-carbon groups for
methylation reactions. The MTHFR gene produces an
enzyme important in folate metabolism.
The aim of study was to analyze an association of folic
acid concentrations and genetic variants in the MTHFR
gene with breast cancer risk in patients with BRCA1
mutation.
Study group consisted of 99 patients with breast or
ovarian cancer and 198 healthy women from the paired
control group; all cases and controls were carriers of one
out of three Polish founder mutations (C61G, 4153delA,
5382insC). Folic acid concentration was quantitatively
measured in blood plasma by HPLC chromatography
(Flexar HPLC, Perkin Elmer). Two functional SNPs in
the MTHFR gene, 677 C>T (rs1801133) and 1298 A>C
(rs1801131), both associated with reduced enzyme activ-
ity, have been tested on LightCycler 480 (Roche Diagnos-
tic) by Taqman or Simple Probe approach.
The mean levels of folic acid were compared for cases
and controls. Women who have level of folic acid in the
range of 53.3 mg/l - 83.1 mg/l had a significantly lower
risk of breast or ovarian cancer (OR = 0.55, p = 0.0087) –
comparison to quartile with the lowest concentration.
The analysis of correlation between the level of folic acid
and tested genetic variants in the MTHFR gene gave the
following results:
- for carriers of MTHFR 1298AA the lowest risk of
cancer was for folic acid concentration >81 mg/l (OR =
0,25, p = 0,0292 , CI = 0,07948-0,7863)
- for carriers of MTHFR 1298AA +AC the lowest risk
of cancer was for folic acid concentration in the range
of 51,44 to 82-82 mg/l (OR = 0,25, p = 0,009, CI =
0,09-0,67)
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Table 1
FOLATE [mg/] CASES CONTROLS OR p-value
3,34 - 34,28 13 17 0,77 0,79
34,5 - 53,44 15 15 1,0 -
53,75 - 80,92 8 22 0,36 0,11
81,07 - 284,79 6 24 0,25 0,03
Table 2
FOLATE [mg/] CASES CONTROLS OR p-value
4,92-30,83 20 20 1,0 -
31,36-51,29 13 26 0,50 0,17
51,44-82,82 8 32 0,25 0,01
82,94-195,81 15 24 0,62 0,37
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